SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to community excitement around its potential for a short squeeze, driven by molecular-level verification technology for materials. Discussions mention the stock's volatile price action and the possibility of a large upside if the company's Plastic Cycle Token (PCT) gains widespread adoption. Comparisons to other low-float stocks that have experienced rapid gains are also fueling interest.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is trending amid renewed excitement surrounding upcoming satellite launches and their potential impact on global connectivity. Community discussions highlight possible government contracts and the potential for a short squeeze, with some speculating about institutional interest and a broader shift in market sentiment towards growth stocks in the space sector. Despite some skepticism, bullish investors express confidence in AST SpaceMobile's long-term vision and disruptive potential.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending as the community discusses a potential short squeeze, upcoming share authorization vote, and the company's involvement in AI and defense sectors. Traders are weighing positive factors like potential government contracts and growing AI adoption against concerns of dilution. Overall, sentiment is mixed but leaning bullish as the stock attempts to break key resistance levels.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel ($INTC) is trending due to speculation around potential chip deals with major companies like Apple and Tesla, fueling bullish sentiment. The community is actively discussing the stock's breakout potential and anticipating further gains, despite some profit-taking and volatility. Discussions also mention the company's renewed focus on domestic manufacturing and potential for long-term growth in the semiconductor industry.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors discuss recent price movements and potential catalysts, with community members highlighting the company's position in the rare earth mining sector. Conversations revolve around the possibility of a short squeeze and speculation on news related to the company's project in Greenland. Some are drawing comparisons to other rare earth miners and discussing technical analysis signals.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a volatile mix of factors, including discussions of a potential short squeeze and overall quantum computing sector momentum. The community is debating the company's valuation, future prospects, and recent price surge, with some pointing to technical analysis and potential for further gains, while others cite concerns about financials and insider selling. Broader market sentiment and association with meme stocks appear to be influencing the stock's movements.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as the community discusses recent options activity and potential catalysts like the NASA LTV contract award. Bullish sentiment is fueled by the company's strong cash position and strategic acquisitions, while some traders anticipate a short squeeze. The stock's volatile price movement and upcoming IM-3 mission are also key discussion points.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies is trending as traders discuss its potential for a short squeeze similar to other low floaters, with some drawing attention to the company's sector and a notable investor's bullish price target. Community interest appears driven by speculation around photonics, optical computing, and excitement for potential gains. Some traders are wary, citing the company's fundamentals.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as analysts adjust their ratings and price targets leading up to earnings. While some community members see a buying opportunity, others express concern over its valuation and potential downside. Discussions also involve Snowflake's AI initiatives and partnerships with companies like Palantir and Anthropic.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce ($CRM) is trending amid mixed sentiment following earnings, with revenue slightly missing estimates but adjusted EPS exceeding expectations and guidance strengthening. Community discussions revolve around improving profitability, buybacks, and the potential of its generative AI offerings, though analysts hold mixed views on its upside potential. Some traders express frustration over the stock's performance, while others see a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stifel reiterated $ALKS Buy/$42: 
$CNTA $TAK 
We expect ALKS shares to trade higher today on some relief that the initial clinical disclosure from CNTA&#39;s orexin program does not look superior to what we&#39;ve seen from ALKS2680. 
 
The fear/overhang on ALKS was that CNTA could have a much superior profile (we always viewed this as theoretical); that said, the NT1 efficacy disclosure (while it lacks some granularity) does not point to better efficacy. Conversely, CNTA also showed some positive data in NT2/IH -- which we see as validating for the class -- but again the effect is not out of this world, and for ALKS it lays out what we see as a realistic bar. 
 
Ultimately, we think orexins could be a significant blockbuster class and there is room for many players-ALKS, CNTA (Not covered) and Takeda (Not covered) included. But again, the important context here is that for ALKS, there were concerns that CNTA could be clearly superior, which we don&#39;t see.

Mizuho⬆️ $ALKS $45: We publish our pro forma model for the Alkermes + Avadel merger, raising our PT from $40 to $45 and reiterating our OP. 
$CNTA 
We view this transaction as strategically synergistic, firmly positioning Alkermes as a leading player in sleep medicine. 
 
Avadel&#39;s Lumryz -- the only once-nightly oxybate for narcolepsy -- will add &gt;$270M in growing sales and should improve the top-line outlook, particularly ahead of generic Vivitrol competition expected in 2027. 
 
Importantly, the Avadel&#39;s commercial infrastructure should 
(1) allow Alkermes to establish a presence in sleep medicine ahead of Takeda&#39;s OX2R agonist oveporexton&#39;s launch, 
(2) de-risk alixorexton&#39;s launch by leveraging Avadel&#39;s market access and physician relationships, and 
(3) provide potential synergies across sales (oxybates and OX2R agonists are complementary) and operations. 
 
We don&#39;t believe the timing of the deal signals Alkermes losing confidence in the alixorexton program and expect competitive data in November.

StockTwits Web

Alkermes plc

Centessa Pharmaceuticals PLC - ADR

Quantumup

Truist🏁 $ALKS Buy/$50 
 $TAK $AVDL  $CNTA 
Truist in its initiation report said: 
ALKS is a profitable biopharma with base business+cash worth ~$29/sh setting a high floor heading into Ph2 Vibrance-2 data in narcolepsy type 2 (NT2). 
Positive Vibrance-1 in NT1 reported in Sept de-risks imminent NT2 readout. NT1 alone is worth $8/sh in our SOTP valuation. 
NT2 and IH contribute $8/sh and $5/sh, respectively. 
 
ALKS is doubling down in sleep space with the acquisition of Avadel, a strategic move that gives ALKS first-mover advantage over Takeda. 
 
Current leading narcolepsy drugs are only at ~10% penetration generating ~$3B in sales. 
 
Orexin agonists, including ALKS&#39; alixorexton, are poised to become 1st line therapies and expand mkt. Initiate BUY &amp; $50 PT.

Takeda Pharmaceutical Co Ltd (ADR)

 
We expect ALKS shares to trade higher today on some relief that the initial clinical disclosure from CNTA's orexin program does not look superior to what we've seen from ALKS2680. 
 
The fear/overhang on ALKS was that CNTA could have a much superior profile (we always viewed this as theoretical); that said, the NT1 efficacy disclosure (while it lacks some granularity) does not point to better efficacy. Conversely, CNTA also showed some positive data in NT2/IH -- which we see as validating for the class -- but again the effect is not out of this world, and for ALKS it lays out what we see as a realistic bar. 
 
Ultimately, we think orexins could be a significant blockbuster class and there is room for many players-ALKS, CNTA (Not covered) and Takeda (Not covered) included. But again, the important context here is that for ALKS, there were concerns that CNTA could be clearly superior, which we don't see.